These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1036972)

  • 1. [Results obtained with chemotherapy of ovarian cancer respecting its morphological structure (author's transl)].
    Skoda V; Cizková J; Hrádek D; Jandová A; Janousková M; Laurová L
    Cesk Gynekol; 1976 Dec; 41(10):716-17. PubMed ID: 1036972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of a directed chemotherapy in ovarian cancer (author's transl)].
    Gazárek F; Kudela M; Talas M; Fingerová H
    Cesk Gynekol; 1976 Dec; 41(10):719-21. PubMed ID: 1036973
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy as a part of a complex treatment of ovarian cancer (author's transl)].
    Kucera F; Ptácková B
    Cesk Gynekol; 1976 Dec; 41(10):721-2. PubMed ID: 1009602
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
    Skoda V; Elis J; Jandová A; Laurová L; Novotná J; Perlík F
    Neoplasma; 1971; 18(5):471-2. PubMed ID: 5165867
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].
    Chylak V; Kolarić K; Krusić J
    Lijec Vjesn; 1987 Jun; 109(6):230-4. PubMed ID: 3309515
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cytembena and cyclophosphamide in the treatment of advanced neoplasias of the digestive tract (author's transl)].
    Matĕjková E; Rezábek K; Polák E
    Cesk Gastroenterol Vyz; 1974 Jul; 28(4):279-85. PubMed ID: 4603038
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of cytostatic activities of cytembena and cyclophosphamide during short-term administration to women with gynaecological carcinoma.
    Skoda V; Jandová A; Novotná J
    Neoplasma; 1970; 17(2):175-81. PubMed ID: 5269150
    [No Abstract]   [Full Text] [Related]  

  • 8. Status report of Mayo Clinic studies.
    Edmonson JH
    Natl Cancer Inst Monogr; 1975 Oct; 42():167-8. PubMed ID: 1243994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ifosfamide in comparison with cyclophosphamide in advanced ovarian carcinomas (author's transl)].
    Teufel G; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1976 Mar; 36(3):274-9. PubMed ID: 1261795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclophosphamide on ascitic cancer cells.
    Kitao M; Sato M; Iba N; Hasegawa K
    Yonago Acta Med; 1973 Dec; 17(3):220-6. PubMed ID: 4377366
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytoval therapy in advanced ovarian neoplasms].
    Tatra G; Breitenecker G
    Osterr Z Onkol; 1974; (3-4):66-70. PubMed ID: 4480681
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclophosphamide, cisplatin, and leuprolide acetate in patients with debulked stage III or IV ovarian carcinoma.
    Erickson LD; Hartmann LC; Su JQ; Nielsen SN; Pfeifel DM; Goldberg RM; Levitt R; Stanhope CR
    Gynecol Oncol; 1994 Aug; 54(2):196-200. PubMed ID: 8063245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution to the chemotherapy of ovarian neoplasms].
    Kwaśniewska-Rokicińska ; Jopkiewicz Z
    Pol Tyg Lek; 1967 Jul; 22(20):1153-4. PubMed ID: 4168670
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II trial of cytembena in patients with advanced ovarian and breast cancer.
    Falkson HC; Falkson G
    Cancer Treat Rep; 1976 Nov; 60(11):1655-8. PubMed ID: 1037286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome.
    Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with advanced ovarian carcinoma treated with Penberol.
    Novotná J; Andrysek O; Kobilková J; Laurová L
    Neoplasma; 1983; 30(2):245-50. PubMed ID: 6302531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Attempts of the chemotherapy of cancer of the uterine neck (author's transl)].
    Kucera F; Ptácková B
    Cesk Gynekol; 1976 Dec; 41(10):732. PubMed ID: 1036976
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with a combination therapy of metastasising genital and mammary carcinomas (author's transl)].
    Brachetti A; Leonhardt A; Limburg H; Osswald H; Schmähl D
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2037-42. PubMed ID: 4216809
    [No Abstract]   [Full Text] [Related]  

  • 20. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.